Illumina, Inc. Price Today

Illumina, Inc.
ILMN
Healthcare
$17.29B
💰
Market Cap
0
💸
Price to Earnings
$-26.6
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
8 |
Strong Buy |
5 |
Hold |
9 |
Sell |
2 |
Strong Sell |
2 |
ILMN Price Forecast Target
109.2 👉 318.0 +191%
ILMN EPS Forecast
-26.6 👉 2.3 +-109%
Financials
Profit Margin
-94 %
Revenue Growth
1.2 %
Dividend
$ 0
Held Percent
0.3% - Insiders
93.5% - Institutions
6.2% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $2.9B
-
💰 Baillie Gifford and Company $2.6B
-
💰 Blackrock Inc. $2.5B
-
💰 Morgan Stanley $1.4B
-
💰 State Street Corporation $1.3B
Stock Ideas
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…Steven Cohen Portfolio
Steven Cohen, the legendary trader and billionaire founder of Stamford-based SAC Capital, has established himself as a force to be reckoned with in the hedge fund industry. With a staggering net worth of $8 billion and an impressive $14 billion in …📮FAQ
Some Frequently Asked Questions.

The Illumina, Inc. industry is Diagnostics & Research

The Illumina, Inc. sector is Healthcare

The Illumina, Inc. forecasted predicted Price to Earnings PE ratio is 48.1

The Illumina, Inc. Price to Earnings PE ratio is 0

The Market Capitalization of Illumina, Inc. is $17.29B

There are total of 157943825 float shares with 93.5% held by Institutions and 0.3% held by insiders

The MIllumina, Inc. forecasted Earnings per Share EPS is $2.3

The Illumina, Inc. Earnings per Share EPS is -26.6

The Illumina, Inc. company has $3145000000 gross profits with -94 profit margins

The Illumina, Inc. Earnings Growth is 0% with 0% quarterly earnings growth

The Illumina, Inc. Revenue is $4461000192 with 0.012 revenue growth

The price target for Illumina, Inc. stock is $318.0 for the high target and $100.0 for the low target

The consensus analyst recommendations for Illumina, Inc. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.

The consensus analyst recommendations for Illumina, Inc. is Hold, with the following breakdown:
- Buy: 8
- Strong Buy: 5
- Hold: 9
- Sell: 2
- Strong Sell: 2

The Beta of Illumina, Inc. is 1.1

The dividend of Illumina, Inc. is $0

The dividend yield of Illumina, Inc. is 0.0217%

The biggest institutional and mutual fund holders of Illumina, Inc. stock are
- Vanguard Group Inc
- Baillie Gifford and Company
- Blackrock Inc.
- Morgan Stanley

The Illumina, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0